During the period from 2023 to 2031, the market for Spine Biologics is anticipated to expand at a CAGR of 4.5%, propelled by advances in biotechnology and rising demand for minimally invasive procedures in the treatment of spinal disorders. Spine biologics refers to biological substances used in spinal fusion surgeries to stimulate bone growth, promote healing, and enhance spinal stability. ...
Read More »
Mobile Computing Today News from the Mobile World
